Twitxy Saved

TipRanks

Verified account This account is verified because it's an official organization on X. Learn more

@TipRanks

Your source for breaking stock news!

TipRanks Sale Links & More: linktr.ee/tipranks2
1.7K Following 45K Followers 38K Posts

Latest posts 5

TipRanks Verified account @TipRanks
πŸ”Ό $AMD upgraded to Outperform from Perform at Oppenheimer

Oppenheimer analyst Rick Schafer upgraded AMD to Outperform from Perform with a $600 price target.

The company reported another bullish earnings report, the analyst tells investors in a research note.

The firm says AMD's server and data center success is "undeniable." It sees favorable pricing trends as AMD negotiates next generation deals as an incumbent.
TipRanks Verified account @TipRanks
Wall Street lowers its price targets on IonQ $IONQ following its Q3 earnings, despite strong demand and raised revenue guidance:

Jefferies: $80 β†’ $65 (Buy) – Strong results signal quantum computing demand shifting toward commercial deployment, with profitability gaining relevance.

Mizuho: $52 β†’ $42 (Outperform) – Lowered its price target while maintaining a positive rating.

Morgan Stanley: $43 β†’ $40 (Equal Weight) – Revenue beat expectations, FY26 guidance increased, and Superion 256 sold out for 2027.
5 replies 7 reposts 55 likes 29K views View on X
TipRanks Verified account @TipRanks
Oscar Health $OSCR price target lowered to $45 from $48 at Piper Sandler

Piper Sandler lowered the firm's price target on Oscar Health to $45 from $48 and keeps an Overweight rating on the shares following the Q3 beat and raise.

The firm notes the company clarified the 2027 outlook for total Individual ACA market wide enrollment. Piper pares back its membership estimates, which flow through to earnings.
1 replies 4 reposts 46 likes 6.3K views View on X
TipRanks Verified account @TipRanks
Wall Street updates its price targets on Uber $UBER following its Q3 earnings, with analysts highlighting driver supply constraints and near-term margin pressure:

UBS: $106 β†’ $107 (Buy) – Mobility growth missed expectations due to driver shortages, but improving supply supports a recovery.

KeyBanc: $105 β†’ $95 (Overweight) – Diversification supports results, but driver supply investments may pressure margins.

Wells Fargo: $92 β†’ $87 (Overweight) – Supply investments should support Mobility growth and strengthen Uber’s competitive position.

Barclays: $106 β†’ $100 (Overweight) – Steady Q3 performance, but driver supply volatility weighed on growth.

Bernstein: $95 β†’ $90 (Outperform) – Mixed Q3 results, but solid EBITDA and EPS support the growth outlook.

Canaccord: $72 β†’ $70 (Hold) – Results met expectations, but Mobility and Delivery bookings growth slowed.